New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
May 18, 2015
16:21 EDTAAPLOn The Fly: Top stock stories for Monday
Stocks on Wall Street advanced in Monday trading, sending the Dow Jones Industrial Average and the S&P 500 to new all-time closing highs. The early part of the day saw the market move in a narrow range, but by early afternoon the market punched through its upper range and moved to session highs. The market drifted throughout the afternoon as the news flow was quiet and the trading volume remained light. ECONOMIC EVENTS: In the U.S., the National Association of Home Builders’ confidence index fell 2 points to a reading of 54 in May, missing expectations for a 1 point increase to a reading of 57. COMPANY NEWS: Shares of Apple (AAPL) advanced $1.47, or 1.14%, to $130.24 after noted investor Carl Icahn stated in an open letter to the company's CEO that he thinks other investors, analysts and the news media continue to misunderstand Apple and that its stock is "worth $240 today." Icahn urged Apple CEO Tim Cook to take advantage by launching a "much larger buyback" of the iPhone maker's shares. Separately, FBR Capital analysts Daniel Ives and James Moore wrote this morning in a note to investors that the Street is still underestimating Apple's growth outlook in China. The analysts believe that Apple's China revenue will exceed its revenue from the Americas in fiscal 2017... Endo International (ENDP) slid $4.53, or 5.31%, to $80.82 after the company agreed to pay $8B for privately held Par Pharmaceutical, which will roughly double Endo’s generics revenue and place its generics business among the top five as measured by U.S. sales. MAJOR MOVERS: Among the notable gainers was Ann Inc. (ANN), which surged $7.69, or 19.87%, to $46.40 after agreeing to be acquired by Ascena Retail Group (ASNA) for about $2.15B in cash and stock. Ascena, which agreed to pay $37.34 in cash and 0.68 of a share of its own common stock in exchange for each share of the parent of the Ann Taylor brand, slipped 14c, or 0.99%, to $14.07 after announcing the deal. Also higher was Achillion (ACHN), which rose $1.41, or 14.79%, to $10.98 after the company cancelled its presentation at the UBS Global Healthcare Conference. Conference cancellations often generate speculation as to whether a company is engaged in merger or acquisition talks. Among the noteworthy losers was Eleven Biotherapeutics (EBIO), which dropped $8.29, or 69.26%, to $3.68 after announcing the company’s Phase 3 study of its lead drug candidate, EBI-005, in moderate to severe dry eye disease did not meet either of its two co-primary endpoints. Also lower were shares of Weibo (WB), which fell 87c, or 5.24%, to $15.73 after the shares were downgraded to Hold from Buy at Summit Research. INDEXES: The Dow rose 26.32, or 0.14%, to 18,298.88, the Nasdaq gained 30.15, or 0.6%, to 5,078.44, and the S&P 500 added 6.47, or 0.3%, to 2,129.20.
16:14 EDTGEColfax announces acquisition of Roots blowers & compressors
Colfax Corporation (CFX) announced that it has entered into a binding agreement to acquire the Roots blowers and compressors business unit , also known as Industrial Air & Gas Technologies, from GE (GE) Oil & Gas for a cash consideration of $185M. Roots is a leading supplier of blower and compressor technologies which service a broad range of end markets, including water treatment, chemical production, and power generation. This acquisition will build on Howden's global strength in compressors and blowers and will add important application expertise and product solutions to the portfolio. In 2014, Roots had approximate revenues of $155 million and EBITDA of $22M. In making the announcement, Steve Simms, President and Chief Executive Officer of Colfax, stated, "I am delighted to welcome the Roots team to Colfax. We are excited by the opportunities created by combining the Roots capabilities and application expertise with Howden's global footprint and continuous improvement culture. Like Howden, the Roots business has spent more than 150 years developing market leading products and solutions, and we look forward to continuing to innovate and grow." Mr. Simms continued, "Strengthening our businesses through bolt-on acquisitions is a core part of our strategy, and we continue to see a robust pipeline of opportunities."Closing of the acquisition is expected early in the third quarter following the fulfillment of certain conditions.
16:00 EDTAAPLOptions Update; May 18, 2015
Subscribe for More Information
14:04 EDTAAPLEarnings Watch: Wal-Mart sees Q1 EPS 95c-$1.10, U.S. SSS up 1%-2%
Subscribe for More Information
13:49 EDTAAPLEarnings Watch: Home Depot sees FY15 EPS $5.11-$5.17, revenue growth 3.5%-4.7%
Home Depot (HD), a home improvement retailer, is scheduled to report first quarter results before the market opens on Tuesday, May 19, with a conference call scheduled for 9:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.15 on revenue of $20.82B, according to First Call. The consensus range for EPS is $1.12-$1.19 on revenue of $20.47B-$21.26B. LAST QUARTER: Home Depot reported fourth quarter adjusted EPS of $1.00 on revenue of $19.16B, beating analysts' consensus estimates for 89c and $18.7B, respectively. The company said same-store sales increased 7.9%, with U.S. SSS up 8.9%. The company forecast fiscal year 2015 EPS of $5.11-$5.17 on revenue growth of 3.5%-4.7%, against estimates at that time for $5.23 and $86.46B, respectively. Home Depot also guided to FY15 SSS growth of 3.3%-4.5% and said it expected FY15 gross margin to be flat, with a tax rate of approximately 37%. Capital expenditures for FY15 were foreseen at $1.6B, with cash flow from business at $9B. In addition to reporting better than expected Q4 earnings, Home Depot also announced an $18B share repurchase program and increased its quarterly dividend by 26% to 59c. NEWS: On its Q4 earnings conference call, Home Depot said it expected moderate GDP growth and housing recovery to drive growth in 2015. The company noted that if foreign currency rates continued as they were in February, sales in 2015 could be negatively impacted by $1B. At March's Raymond James conference, Home Depot backed its guidance for FY15. The company also said it sees FY15 operating margin approximately 60bps to greater than 13%. The company plans to open six new stores in FY15, including five stores in Mexico and one in Canada. The retailer is targeting FY15 share repurchases of $4.5B. On May 5, MacRumors reported that Home Depot may begin phasing out support for Apple Pay (AAPL) at its retail stores. Point72 Asset Management announced that it liquidated its stake during the quarter. STREET RESEARCH: In March, Oppenheimer said it believes that Home Depot has a number of positive catalysts, including solid U.S. consumer spending trends, significant slack in the U.S, housing recovery, improving market sentiment and investors' interest in domestic plays as the dollar strengthens. The firm raised its price target to $133 from $115 and kept an Outperform rating on the stock. On April 26, Barron's said shares of Home Depot could rise towards $124 as the housing market regenerates and demand for renovation grows. BofA/Merrill said the home improvement is one of the more attractive areas within retail and recommended buying Home Depot. During the quarter, Home Depot was initiated with a Hold rating and $108 target at Cantor. PRICE ACTION: Over the last three months, Home Depot shares are up over 1.5%. Ahead of Tuesday's earnings, Home Depot is fractionally higher at $113.77.
12:51 EDTAAPLOn The Fly: Top stock stories at midday
Subscribe for More Information
11:49 EDTAAPLApple readying new features for Apple Watch, 9to5Mac reports
Subscribe for More Information
11:26 EDTAAPLFBR, Icahn both say Apple being underappreciated
Subscribe for More Information
11:08 EDTAAPLIcahn says Apple shares 'worth $240 today,' urges 'much larger' buyback
In an open letter to Apple CEO Tim Cook posted to his Shareholder's Square Table website, investor Carl Icahn stated that he believes Apple shares "are worth $240 today." With Apple’s shares trading for "just $128.77 per share" versus Icahn's valuation of $240 per share, the investor said it is the time for a "much larger buyback" to be launched by the company. Apple’s earnings multiple has stayed "irrationally discounted," according to Icahn, since investors, analysts and the news media continue to misunderstand Apple and "generally fail to value Apple’s net cash separately from its business, fail to adjust earnings to reflect Apple’s real cash tax rate, fail to recognize the growth prospects of Apple entering new categories, and fail to recognize that Apple will maintain pricing and margins."
11:04 EDTAAPLCarl Icahn says Apple shares 'worth $240 today'
Subscribe for More Information
09:36 EDTGE, AAPLActive equity options trading on open
Subscribe for More Information
09:36 EDTAAPLAppeal says Samsung $930M damages to Apple must be adjusted, Bloomberg reports
The U.S. Court of Appeals for the Federal Circuit ruled that Samsung (SSNLF) did infringe Apple’s (AAPL) design patents, but did not violate Apple’s trade dress, meaning the $930M damages award to Apple must be adjusted, reported Bloomberg. Reference Link
09:26 EDTAAPLApple gets mixed ruling from appeals court in Samsung case, Bloomberg reports
Subscribe for More Information
08:28 EDTAAPLApple Watch volume down but mix is up. says UBS
Subscribe for More Information
08:07 EDTGESplunk appoints Snehal Antani as Chief Technology Officer
Subscribe for More Information
07:29 EDTAAPLApple China growth underappreciated by investors, says FBR Capital
Subscribe for More Information
06:56 EDTGEGE, Emerson said to be mulling bids for Aveva, Sunday Times reports
Subscribe for More Information
06:13 EDTAZNAstraZeneca to invest $285M in new biologics manufacturing facility in Sweden
AstraZeneca announced that it plans to invest approximately $285M in a new high-tech facility for manufacturing of biological medicines in Södertälje, Sweden. The new plant will be focused on filling and packaging of protein therapeutics. It is anticipated that the new facility will supply medicines for clinical trial programs of AstraZeneca and MedImmune, the company’s global biologics research and development arm, from the end of 2018, and will deliver finished products for commercial use once fully operational by 2019. Södertälje is currently home to AstraZeneca’s largest global tablets and capsules manufacturing facility and is also a launch platform site for the company, with specialist capabilities on-site that allow large-scale production of new medicines, working closely with the research and development organisation. By locating the new manufacturing plant in Södertälje, the company will combine its expertise in biologics with the well-established culture of operational excellence that exists within the Sweden Operations unit. The planned investment will, subject to relevant approvals by the local authorities, create between 150 and 250 highly skilled new roles at AstraZeneca by 2019. The new manufacturing facility in Sweden will support the progression of drug candidates across the main therapy areas and be aligned with investments being made in the current biologics manufacturing centers, such as the expansion in Frederick, Maryland, announced in November.
06:05 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
May 17, 2015
18:04 EDTAAPLApple acquires Coherent Navigation, NYT says
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use